首页 › 镰状细胞病 › 阿拉巴马州 › Birmingham
Birmingham AL 镰状细胞病临床试验
14项针对 镰状细胞病的研究正在 Birmingham及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
招募中3 期
- University Of Alabama, Birmingham
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
招募中1 期
- University of Alabama at Birmingham, Birmingham
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
招募中3 期
- Uni of Alabama at Birmingham, Birmingham
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
招募中1/2 期欢迎健康志愿者
- University of Alabama Birmingham, Birmingham
SCD Stem Cell Mobilization and Apheresis Using Motixafortide
招募中1 期
- University of Alabama at Birmingham, Birmingham
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
招募中1/2 期欢迎健康志愿者
- University of Alabama at Birmingham, Birmingham
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
招募中3 期
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
Early Life Exposures Among Children With Sickle Cell Disease
招募中
- University of Alabama at Birmingham, Birmingham
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
招募中4 期
- University Of Alabama, Birmingham
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
招募中观察性研究
- Children's of Alabama (MRD-HCT), Birmingham
- Children's of Alabama (NT-DMT), Birmingham
Cognitive Remediation Intervention to Prepare for Transition of Care
招募中2 期
- University of Alabama at Birmingham, Birmingham
A Long-term Follow-up Study in Patients Who Received BEAM-101
招募中观察性研究
- University of Alabama at Birmingham, Birmingham
HPC Offered for PRESERVE Expansion
招募中观察性研究
- University of Alabama, Birmingham, Birmingham
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
招募中观察性研究
- University of Alabama, Birmingham (UAB), Birmingham
其他城市的 镰状细胞病试验
- Atlanta, GA22 项研究
- Washington, DC20 项研究
- Memphis, TN18 项研究
- Chicago, IL18 项研究
- Philadelphia, PA15 项研究
- New York City, NY13 项研究
- St. Louis, MO12 项研究
- Houston, TX10 项研究
- Durham, NC10 项研究
- Boston, MA10 项研究
- Cincinnati, OH10 项研究
- Pittsburgh, PA9 项研究
Birmingham的其他研究
- 癌症（所有类型）31 项研究
- 乳腺癌24 项研究
- 肥胖症23 项研究
- 卵巢癌23 项研究
- 非小细胞肺癌22 项研究
- 急性髓系白血病21 项研究
- 多发性骨髓瘤18 项研究
- 心血管疾病17 项研究
- 慢性阻塞性肺病17 项研究
- 超重16 项研究
- 囊性纤维化16 项研究
- 子宫内膜癌16 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。